Chronic caffeine treatment reverses memory impairment and the expression of brain BNDF and TrkB in the PS1/APP double transgenic mouse model of Alzheimer's disease

Massoud F and Gauthier S: Update on the pharmacological treatment of Alzheimer’s disease. Curr Neuropharmacol. 1:69–80. 2010.

Ritter JM: Drugs for Alzheimer’s disease. Brit J Clin Pharmacol. 4:501–503. 2012.

Fisone G, Borgkvist A and Usiello A: Caffeine as a psychomotor stimulant: mechanism of action. Cell Mol Life Sci. 7:857–872. 2004. View Article : Google Scholar : PubMed/NCBI

Ritchie K, Carrière I, de Mendonca A, et al: The neuroprotective effects of caffeine: a prospective population study (the Three City Study). Neurology. 69:536–545. 2007. View Article : Google Scholar : PubMed/NCBI

Santos C, Lunet N, Azevedo A, et al: Caffeine intake is associated with a lower risk of cognitive decline: a cohort study from Portugal. J Alzheimers Dis. 20:S175–S185. 2010.PubMed/NCBI

Maia L and de Mendonça A: Does caffeine intake protect from Alzheimer’s disease? Eur J Neurol. 9:377–382. 2002.

Arendash GW, Mori T, Cao C, et al: Caffeine reverses cognitive impairment and decreases brain amyloid-β levels in aged Alzheimer’s disease mice. J Alzheimers Dis. 17:661–680. 2009.PubMed/NCBI

Arendash G, Schleif W, Rezai-Zadeh K, et al: Caffeine protects Alzheimer’s mice against cognitive impairment and reduces brain (beta)-amyloid production. Neuroscience. 142:941–952. 2006.

Bekinschtein P, Cammarota M, Igaz LM, et al: Persistence of long-term memory storage requires a late protein synthesis-and BDNF-dependent phase in the hippocampus. Neuron. 53:261–277. 2007. View Article : Google Scholar : PubMed/NCBI

Peng S, Wuu J, Mufson EJ and Fahnestock M: Precursor form of brain-derived neurotrophic factor and mature brain-derived neurotrophic factor are decreased in the pre-clinical stages of Alzheimer’s disease. J Neurochem. 93:1412–1421. 2005.PubMed/NCBI

Ferrer I, Marín C, Rey MJ, et al: BDNF and full-length and truncated TrkB expression in Alzheimer disease. Implications in therapeutic strategies. J Neuropathol Exp Neurol. 58:729–739. 1999. View Article : Google Scholar : PubMed/NCBI

Kemppainen S, Rantamäki T, Jerónimo-Santos A, et al: Impaired TrkB receptor signaling contributes to memory impairment in APP/PS1 mice. Neurobiol Aging. 33:e23–e39. 2011.PubMed/NCBI

Lynch G, Kramar EA, Rex CS, et al: Brain-derived neurotrophic factor restores synaptic plasticity in a knock-in mouse model of Huntington’s disease. J Neurosci. 27:4424–4434. 2007.PubMed/NCBI

Zeitlin R, Patel S, Burgess S, et al: Caffeine induces beneficial changes in PKA signaling and JNK and ERK activities in the striatum and cortex of Alzheimer’s transgenic mice. Brain Res. 1417:127–136. 2011.PubMed/NCBI

Prasanthi JR, Dasari B, Marwarha G, et al: Caffeine protects against oxidative stress and Alzheimer’s disease-like pathology in rabbit hippocampus induced by cholesterol-enriched diet. Free Radic Biol Med. 49:1212–1220. 2010.PubMed/NCBI

Alhaider IA, Aleisa AM, Tran TT, et al: Chronic caffeine treatment prevents sleep deprivation-induced impairment of cognitive function and synaptic plasticity. Sleep. 33:437–444. 2010.PubMed/NCBI

Cao C, Wang L, Lin X, et al: Caffeine synergizes with another coffee component to increase plasma GCSF: linkage to cognitive benefits in Alzheimer’s mice. J Alzheimers Dis. 25:323–335. 2011.PubMed/NCBI

Nagahara AH, Merrill DA, Coppola G, et al: Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer’s disease. Nat Med. 15:331–337. 2009.